Cargando…

Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes

Lung cancer is one of the most frequently diagnosed cancers worldwide and the leading cause of cancer-related death. The 2021 World Health Organization (WHO) classification provided a detailed and updated categorization of lung adenocarcinomas with a special focus on rare histological types, includi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mogavero, Andrea, Bironzo, Paolo, Righi, Luisella, Merlini, Alessandra, Benso, Federica, Novello, Silvia, Passiglia, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302096/ https://www.ncbi.nlm.nih.gov/pubmed/37374074 http://dx.doi.org/10.3390/life13061291

Ejemplares similares

Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations
por: Bironzo, Paolo, et al.
Publicado: (2021)

Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?—a literature review
por: Leone, Gianmarco, et al.
Publicado: (2020)

Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma
por: Napoli, Francesca, et al.
Publicado: (2021)

Immunohistochemistry with 3 different clones in anaplastic lymphoma kinase fluorescence in situ hybridization positive non-small-cell lung cancer with thymidylate synthase expression analysis: a multicentre, retrospective, Italian study
por: Bironzo, Paolo, et al.
Publicado: (2022)

Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours
por: Dumoulin, Daphne W., et al.
Publicado: (2023)

Future perspectives from lung cancer pre-clinical models: new treatments are coming?
por: Bersani, Francesca, et al.
Publicado: (2020)

Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma
por: Bria, Emilio, et al.
Publicado: (2015)

New emerging targets in cancer immunotherapy: the role of VISTA
por: Tagliamento, Marco, et al.
Publicado: (2020)

Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity
por: Bersani, Francesca, et al.
Publicado: (2023)

Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer
por: Mariniello, Annapaola, et al.
Publicado: (2022)

Targeting chimeras fusion proteins in non-small cell lung cancer: where are we going?
por: Passiglia, Francesco, et al.
Publicado: (2020)

Should adjuvant treatment be offered to patients with stage IB non-small cell lung cancer?
por: Passiglia, Francesco, et al.
Publicado: (2023)

Local for advanced, is this a paradox?
por: Bungaro, Maristella, et al.
Publicado: (2021)

Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review
por: Passiglia, Francesco, et al.
Publicado: (2022)

Improving lung cancer outcomes through smoking cessation: the Women Against Lung Cancer in Europe (WALCE) experience
por: Capelletto, Enrica, et al.
Publicado: (2020)

Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition
por: Napoli, Francesca, et al.
Publicado: (2022)

Correction to: Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition
por: Napoli, Francesca, et al.
Publicado: (2022)

Detection and characterization of classical and “uncommon” exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing
por: Righi, Luisella, et al.
Publicado: (2013)

Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma
por: Anobile, Dario P., et al.
Publicado: (2021)

Smooth muscle cell fate decisions decipher a high-resolution heterogeneity within atherosclerosis molecular subtypes
por: Zhang, Ge, et al.
Publicado: (2022)

Deciphering cancer heterogeneity: the biological space
por: Roessler, Stephanie, et al.
Publicado: (2014)

Deciphering White Adipose Tissue Heterogeneity
por: Luong, Quyen, et al.
Publicado: (2019)

Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes?
por: Galati, Francesca, et al.
Publicado: (2022)

Targeting KRAS in NSCLC: Old Failures and New Options for “Non-G12c” Patients
por: Jacobs, Francesca, et al.
Publicado: (2021)

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?
por: Passiglia, Francesco, et al.
Publicado: (2021)

The Role of Systems Biology in Deciphering Asthma Heterogeneity
por: Hachim, Mahmood Yaseen, et al.
Publicado: (2022)

Pathologic heterogeneity of lung adenocarcinomas: A novel pathologic index predicts survival
por: Lee, Geewon, et al.
Publicado: (2016)

Deciphering the triad of infection, immunity and pathology
por: Graw, Frederik
Publicado: (2021)

An overview of functional genomic tools in deciphering insecticide resistance
por: Homem, Rafael A, et al.
Publicado: (2018)

Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma
por: González-Borja, Iranzu, et al.
Publicado: (2021)

Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration
por: Scialò, Carlo, et al.
Publicado: (2019)

SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma
por: Salaroglio, Iris Chiara, et al.
Publicado: (2022)

COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery
por: Bungaro, Maristella, et al.
Publicado: (2022)

Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: Evidence for clinico-pathologic subtypes
por: Takeuchi, Ryoko, et al.
Publicado: (2016)

Deciphering Subtype-Selective Modulations in TRPA1 Biosensor Channels
por: Kozai, Daisuke, et al.
Publicado: (2015)

Exploring the immune-checkpoint inhibitors’ efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease
por: Passiglia, Francesco, et al.
Publicado: (2021)

High-throughput sequencing to decipher the genetic heterogeneity of deafness
por: Brownstein, Zippora, et al.
Publicado: (2012)

Deciphering anomalous heterogeneous intracellular transport with neural networks
por: Han, Daniel, et al.
Publicado: (2020)

Deciphering neural heterogeneity through cell lineage tracing
por: Figueres-Oñate, María, et al.
Publicado: (2020)

Deciphering the Transcriptomic Heterogeneity of Duodenal Coeliac Disease Biopsies
por: Wolf, Johannes, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ib4evnbfoibhl7bo5mfko7qai6